Skip to search formSkip to main contentSkip to account menu

ESHAP regimen

Known as: Etoposide-Solumedrol-High Dose Ara-C, Platinol Regimen 
A regimen consisting of etoposide, methylprednisolone, high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and non… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Amac: Gectigimiz yillarda lenfomalarin tedavisinde buyuk ilerleme gerceklestirilmistir. CD20 pozitif non-Hodgkin lenfomalarin… 
2011
2011
s 2005;106:2676. 8. Moskowitz CH, Bertino JR, Glassman JR, et al. Ifosfamide, carboplatin, and etoposide: a highly effective… 
2009
2009
Objective:To observe the efficacy and the side effect of ESHAP in the treatment of refractory or recurrent Non-Hodgkin's lymphoma… 
2007
2007
Objective To evaluate the efficacy and safety of ESHAP regimen,as a salvage regimen, in treating patients with relapsed or… 
2004
2004
Objective:To evaluate the effects of ESHAP regimen in treatment of refractory and relapsing lymphoma.Method:36 patients with… 
2002
2002
Fludarabine, a purine analog with an excellent activity against indolent lymphoid malignancies, has been associated with serious…